v3.26.1
Schedule of segment reporting information, by segment (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Operating expenses:    
Personnel and related expenses $ 11,414 $ 11,805
Office space rental related expenses 4,532 3,999
Development expenses 4,329 3,059
Professional services and insurance 5,747 4,600
Depreciation 424 408
Other general and administrative expenses 1,110 806
Other income (expense), net (947) (1,191)
Segment net loss 26,609 23,486
Biopharm Division [Member]    
Operating expenses:    
Personnel and related expenses 10,275 10,053
Office space rental related expenses 4,213 3,999
Development expenses 4,329 2,765
Professional services and insurance 4,911 4,600
Depreciation 411 378
Other general and administrative expenses 785 806
Other income (expense), net (821) (1,347)
Segment net loss 24,103 21,254
Neurostimulation Division [Member]    
Operating expenses:    
Personnel and related expenses 1,139 1,752
Office space rental related expenses 319
Development expenses 294
Professional services and insurance 836
Depreciation 13 30
Other general and administrative expenses 325
Other income (expense), net (126) 156
Segment net loss $ 2,506 $ 2,232